- Immunomedics: Our Take On This Battleground Stock
- Do You Have News to Share? Get It Published.
- East London residents invited for free lung health MOT
- Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma
- Week In Review: Immunotherapies Dominate The Week's China Biopharma News
Join us in the battle against lung cancer!
For more information, seeget involved!